121 related articles for article (PubMed ID: 33781437)
1. Too Good to be True?
Sebastian M; Stratmann JA; Eberhardt WEE
J Thorac Oncol; 2021 Apr; 16(4):507-508. PubMed ID: 33781437
[No Abstract] [Full Text] [Related]
2. [Treatment of ALK negative metastatic inflammatory myofibroblastic tumor by combination of pembrolizumab and anlotinib: a case report].
Li XS; Li XF; Jin LF; Zhao Y; Shen WZ
Zhonghua Zhong Liu Za Zhi; 2021 Feb; 43(2):240-242. PubMed ID: 33601493
[No Abstract] [Full Text] [Related]
3. Towards precision medicine: CCL2, another brick in the wall?
Charpidou A; Kotteas E; Gaga M
Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30846448
[No Abstract] [Full Text] [Related]
4. Drugs to avoid during pregnancy: omalizumab and montelukast, too many uncertainties.
Prescrire Int; 2014 Feb; 23(146):51. PubMed ID: 24669391
[No Abstract] [Full Text] [Related]
5. [Lung cancer: molecular targeting therapy].
Kobayashi K
Nihon Kokyuki Gakkai Zasshi; 2004 May; 42(5):371-7. PubMed ID: 15168452
[No Abstract] [Full Text] [Related]
6. Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC.
Chu T; Zhong R; Zhong H; Zhang B; Zhang W; Shi C; Qian J; Zhang Y; Chang Q; Zhang X; Dong Y; Teng J; Gao Z; Qiang H; Nie W; Zhao Y; Han Y; Chen Y; Han B
J Thorac Oncol; 2021 Apr; 16(4):643-652. PubMed ID: 33524601
[TBL] [Abstract][Full Text] [Related]
7. [A case report of anlotinib treatment of an advanced lung squamous cell cancer patients without driver gene mutations].
Liu YH; Zhang YW; Li JS; Dai XM
Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):447-448. PubMed ID: 31216831
[No Abstract] [Full Text] [Related]
8. Allergic broncho-pulmonary aspergillosis following treatment with an anti-programmed cell death protein 1 monoclonal antibody therapy.
Pradere P; Michot JM; Champiat S; Danlos FX; Marabelle A; Lambotte O; Albiges L; Le Pavec J
Eur J Cancer; 2017 Apr; 75():308-309. PubMed ID: 28259013
[No Abstract] [Full Text] [Related]
9. Lenvatinib and pembrolizumab in advanced gastric cancer.
Cascinu S
Lancet Oncol; 2020 Aug; 21(8):1004-1005. PubMed ID: 32589865
[No Abstract] [Full Text] [Related]
10. A Step Ahead in Metastatic Renal Cell Carcinoma.
Ravaud A
N Engl J Med; 2021 Apr; 384(14):1360-1361. PubMed ID: 33616313
[No Abstract] [Full Text] [Related]
11. Radiation dose in non-small cell lung cancer: too much of a good thing?
Dilling TJ
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):979-82. PubMed ID: 25539360
[No Abstract] [Full Text] [Related]
12. Targeting Angiogenesis for Advanced Hepatocellular Carcinoma.
Eso Y
Intern Med; 2021 Feb; 60(3):321-322. PubMed ID: 32963171
[No Abstract] [Full Text] [Related]
13. 2014 American Thoracic Society International Conference.
Kang S
Lancet Respir Med; 2014 Jul; 2(7):518-20. PubMed ID: 25140364
[No Abstract] [Full Text] [Related]
14. Inhibition of PD-1 and VEGF in microsatellite-stable endometrial cancer.
Konecny GE
Lancet Oncol; 2019 May; 20(5):612-614. PubMed ID: 30922730
[No Abstract] [Full Text] [Related]
15. Good response to second-line bevacizumab and interferon-alpha in a sunitinib-refractory patient with metastatic renal cell carcinoma.
Pastorelli D; Zustovich F; Faggioni G; Zovato S; Donach M; Nicoletto O; Farina M; Furini L; Ceravolo R; Carli P; Lombardi G
Anticancer Drugs; 2010 Feb; 21(2):210-3. PubMed ID: 19952729
[TBL] [Abstract][Full Text] [Related]
16. Selected Articles from This Issue.
Clin Cancer Res; 2020 Jan; 26(2):323. PubMed ID: 31941683
[No Abstract] [Full Text] [Related]
17. Bevacizumab/chemotherapy in non-small-cell lung cancer: looking for a few good men?
Herbst RS
Clin Lung Cancer; 2008 Mar; 9(2):75-6. PubMed ID: 18501092
[No Abstract] [Full Text] [Related]
18. Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase.
Matsui J; Funahashi Y; Uenaka T; Watanabe T; Tsuruoka A; Asada M
Clin Cancer Res; 2008 Sep; 14(17):5459-65. PubMed ID: 18765537
[TBL] [Abstract][Full Text] [Related]
19. [New chloro derivatives of benzothiopyrano indoles and quinolines].
Fravolini A; Croisy A; Jacquignon P
Farmaco Sci; 1976 Jun; 31(6):418-25. PubMed ID: 1278361
[TBL] [Abstract][Full Text] [Related]
20. Selective endo and exo iodocyclizations in the synthesis of quinolines and indoles.
Hessian KO; Flynn BL
Org Lett; 2006 Jan; 8(2):243-6. PubMed ID: 16408885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
